Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2016.06.048 Byline: Syed S. Mahmood (a)(b), Farhad Abtahian (c), Annemarie E. Fogerty (d), Philip Cefalo (e), Cheryl MacKay (f), Michael R. Jaff (f), Ido Weinberg (f) Abstract: Patients with metastatic carcinoma and venous thromboembolism commonly have contraindications to anticoagulation that prompt the use of retrievable inferior vena cava filters. The aim of this study was to compare the pattern of inferior vena cava filter use, anticoagulation management, and development of inferior vena cava filter-related complications in patients with localized versus metastatic carcinoma. Author Affiliation: (a) Department of Medicine, Massachusetts General Hospital, Boston (b) Cardiology Division, Brigham and Women's Hospital, Boston, Mass (c) Cardiology, Rochester Regional Health Center, NY (d) Department of Hematology and Oncology, Massachusetts General Hospital, Boston (e) Department of Medicine and Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston (f) Fireman Vascular Center, Massachusetts General Hospital, Boston Article Note: (footnote) Funding: None., Conflict of Interest: MRJ reports nonfinancial support from Boston Scientific, nonfinancial support from Cordis Corporation, and personal fees from Cardinal Health, Bi02/Novella, Volcano, VIVA Physicians, a 501 c 3 not-for-profit education and research organization, and the Society for Cardiovascular Angiography and Intervention, outside the submitted work., Authorship: All authors had access to the data and played a role in writing this manuscript..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:130 |
|---|---|
| Enthalten in: |
The American journal of medicine - 130(2017), 1, Seite 77-82.e1 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mahmood, Syed S [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
Anticoagulants |
| doi: |
10.1016/j.amjmed.2016.06.048 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1987449622 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1987449622 | ||
| 003 | DE-627 | ||
| 005 | 20230517132221.0 | ||
| 007 | tu | ||
| 008 | 170207s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amjmed.2016.06.048 |2 doi | |
| 028 | 5 | 2 | |a PQ20170301 |
| 035 | |a (DE-627)OLC1987449622 | ||
| 035 | |a (DE-599)GBVOLC1987449622 | ||
| 035 | |a (PRQ)c1512-8d54d267d6b15684f249511d431c5ead1d9a915837abd2fdccedbcb27e1e0cce0 | ||
| 035 | |a (KEY)0037323020170000130000100077anticoagulationisassociatedwithdecreasedinferiorve | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Mahmood, Syed S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2016.06.048 Byline: Syed S. Mahmood (a)(b), Farhad Abtahian (c), Annemarie E. Fogerty (d), Philip Cefalo (e), Cheryl MacKay (f), Michael R. Jaff (f), Ido Weinberg (f) Abstract: Patients with metastatic carcinoma and venous thromboembolism commonly have contraindications to anticoagulation that prompt the use of retrievable inferior vena cava filters. The aim of this study was to compare the pattern of inferior vena cava filter use, anticoagulation management, and development of inferior vena cava filter-related complications in patients with localized versus metastatic carcinoma. Author Affiliation: (a) Department of Medicine, Massachusetts General Hospital, Boston (b) Cardiology Division, Brigham and Women's Hospital, Boston, Mass (c) Cardiology, Rochester Regional Health Center, NY (d) Department of Hematology and Oncology, Massachusetts General Hospital, Boston (e) Department of Medicine and Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston (f) Fireman Vascular Center, Massachusetts General Hospital, Boston Article Note: (footnote) Funding: None., Conflict of Interest: MRJ reports nonfinancial support from Boston Scientific, nonfinancial support from Cordis Corporation, and personal fees from Cardinal Health, Bi02/Novella, Volcano, VIVA Physicians, a 501 c 3 not-for-profit education and research organization, and the Society for Cardiovascular Angiography and Intervention, outside the submitted work., Authorship: All authors had access to the data and played a role in writing this manuscript. | ||
| 540 | |a Nutzungsrecht: © COPYRIGHT 2017 Elsevier B.V. | ||
| 650 | 4 | |a Complications and side effects | |
| 650 | 4 | |a Care and treatment | |
| 650 | 4 | |a Anticoagulants (Medicine) | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Thromboembolism | |
| 650 | 4 | |a Metastasis | |
| 650 | 4 | |a Carcinoma | |
| 650 | 4 | |a Anticoagulants | |
| 700 | 1 | |a Abtahian, Farhad |4 oth | |
| 700 | 1 | |a Fogerty, Annemarie E |4 oth | |
| 700 | 1 | |a Cefalo, Philip |4 oth | |
| 700 | 1 | |a MacKay, Cheryl |4 oth | |
| 700 | 1 | |a Jaff, Michael R |4 oth | |
| 700 | 1 | |a Weinberg, Ido |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of medicine |d Orlando, Fla. : Elsevier, 1946 |g 130(2017), 1, Seite 77-82.e1 |w (DE-627)129268461 |w (DE-600)80015-6 |w (DE-576)014458861 |x 0002-9343 |7 nnns |
| 773 | 1 | 8 | |g volume:130 |g year:2017 |g number:1 |g pages:77-82.e1 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.amjmed.2016.06.048 |3 Volltext |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1857291758 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 130 |j 2017 |e 1 |h 77-82.e1 | ||